Overcoming Data Overload: How AI and Modernisation Are Transforming Pharma and Biotech

AI is reshaping pharma and biotech. From drug discovery through to commercial strategy, leaders are under pressure to scale innovation and deliver measurable impact. Yet many organisations are still stuck at the pilot stage. The barrier isn’t the technology itself – it’s the data. 

In this webinar, our Global SVP and Head of Data and AI, Richard Pugh joins industry experts to discuss how large pharmaceutical organisations can modernise data ecosystems to fully realise AI’s potential. Together, they examine why strong data foundations are the key to scaling adoption responsibly, securely and in line with regulatory demands. 

What you’ll learn 

• Why AI readiness has become a board-level priority for pharma leaders 

• How enterprise data strategies break down silos and create measurable business value 

• The role of governance in ensuring AI adoption is safe, compliant and trusted 

• Practical steps for moving beyond scattered pilots toward enterprise-wide readiness 

This discussion offers leaders a clear view of the challenges and opportunities ahead. From data integration to compliance frameworks, it highlights the practical measures that enable AI to scale responsibly. 

Watch the webinar recording now to explore how strong data foundations can accelerate responsible, scalable AI adoption in pharma and biotech.